Table 4.
Compound | Experimental model | Cell or animal type | Outcomes offered by the compound | Reference |
---|---|---|---|---|
Resveratrol | Cell-based tyrosinase inhibition | HEK293 cells | Resveratrol was effective to inhibit human tyrosinase | [136] |
Resveratrol | In vivo UV irradiation | Human | Resveratrol inhibited sunburn cell formation | [137] |
Oxyresveratrol | Cell-based tyrosinase inhibition | B16 cells | Oxyresveratrol was effective to inhibit mushroom and murine tyrosinases | [138] |
Oxyresveratrol and 4′-prenyloxyresveratrol | In vitro tyrosinase inhibition | Mushroom tyrosinase | Oxyresveratrol and 4′-prenyloxyresveratrol from mulberry inhibited tyrosinase | [140] |
Resveratrol and oxyresveratrol | Cell-based 3D reconstituted skin | MelanoDerm® | Oxyresveratrol showed higher melanin inhibition than resveratrol | [141] |
Resveratrol and piceatannol | In vitro tyrosinase inhibition | Mushroom tyrosinase and B16 cells | Piceatannol showed higher tyrosinase inhibition than resveratrol | [142] |
Polydatin | Cell-based tyrosinase inhibition | Melan-a cells | Polydatin inhibited melanin content and tyrosinase | [143] |
Polydatin | In vitro tyrosinase inhibition | Mushroom tyrosinase | Polydatin showed higher tyrosinase inhibition than resveratrol | [144] |
Resveratrol and gnectin C | Cell-based tyrosinase inhibition | B16 cells | Resveratrol and gnectin showed a comparable tyrosinase inhibition | [145] |
α-Viniferin | Cell-based tyrosinase inhibition and in vivo melasma | Melan-a cells and human | α-Viniferin decreased melanin index in the patients with melasma | [146] |
Resveratrol in nanoparticles | In vivo UV irradiation | Guinea pig | The nanoparticles decreased melanin granules in skin | [147] |
Resveratrol in SLNs | In vitro tyrosinase inhibition | Mushroom tyrosinase | Resveratrol loaded in SLNs promoted tyrosinase inhibition | [148] |
SLNs, solid lipid nanoparticles; UV, ultraviolet.